Skip to main content
. 2024 Apr 15;24:468. doi: 10.1186/s12885-024-12201-0

Table 3.

Computed tomography findings

TM-positive group
(N = 76)
TM-negative group
(N = 59)
Total
(N = 135)
Cancer
(N = 41)
No cancer
(N = 35)
p* Cancer
(N = 9)
No cancer
(N = 50)
p** p***
CT, n/N(%) 131/135 (97.0) 41/41 (100) 35/35 (100) 1 9/9 (100) 46/50 (92.0) 0.71 0.11
Region, n/N(%)
Cerebral 22/131 (16.8) 10/41 (24.4) 7/35 (20.0) 0.86 2/9 (22.2) 3/46 (6.5) NA 0.06
Cervical 17/131 (13.0) 5/41 (12.2) 3/35 (8.6) 0.89 1/9 (11.1) 8/46 (17.4) NA 0.48
Thoracic 114/131 (87.0) 35/41 (95.1) 30/35 (85.7) 1 7/9 (77.8) 42/46 (91.3) 0.63 0.73
Abdomen and pelvis 113/131 (86.3) 39/41 (95.1) 26/35 (74.3) 0.03 9/9 (100.0) 40/46 (87.0) 0.20 0.73
Suspicious findings, n/N(%) 52/131 (39.7) 36/41 (87.8) 3/35 (8.57) < 1.10 − 4 7/9 (77.8) 6/46 (13.0) 1 0.008
Mass, n/N(%) 40/131 (30.5) 26/41 (63.4) 3/35 (8.6) < 1.10 − 4 7/9 (77.8) 4/46 (8.7) < 1.10 − 4 0.032
Suspicious secondary lesion(s), n/N(%) 27/131 (20.6) 21/41 (51.2) 0 NA 4/9 (44.4) 2/46 (4.3) NA 0.021
Enlarged lymph node(s), n/N(%) 56/131 (42.8) 26/41 (63.4) 11/35 (31.43) 0.003 6/9 (66.7) 13/46 (28.3) 0.06 0.11
Effusion, n/N(%) 40/131 (30.5) 19/41 (46.3) 9/35 (25.7) 0.06 3/9 (33.3) 9/46 (19.6) 0.69 0.08
Thrombosis, n/N(%) 15/131 (11.5) 8/41 (19.5) 2/35 (5.7) NA 2/9 (22.2) 3/46 (6.5) NA 0.63
Relevant for final diagnosis, n/N(%) 62/131 (47.3) 36/41 (87.8) 8/35 (22.9) < 10 − 4 7/9 (77.8) 11/46 (23.9) < 1.10 − 4 < 1.10 − 4
False positive, n/N(%) 9/131 (6.9) 0/41 3/35 (8.6) NA 0/9 6/46 (13.0) NA 0.26

Legends: CT: computed tomography, NA: not applicable

* TM-positive patients with cancer vs. TM-positive patients without cancer

** TM-negative patients with cancer vs. TM-negative patients without cancer

*** TM-positive patients vs. TM-negative patients